Biography and Research Information
OverviewAI-generated summary
Luísa Camacho is a research biologist at the National Center for Toxicological Research. Her work has focused on evaluating alternative skin barrier models for dermal absorption studies, investigating the temporal dynamics of SARS-CoV-2 in wastewater, and examining the influence of race and pigmentation on the human skin barrier. Camacho has also studied the effects of cannabis use on patients presenting to emergency departments for psychosis and validated case definitions for psychotic illness. Her research includes investigating the impact of coadministering black cohosh extract and risedronate on bone health in an ovariectomized rat model, and evaluating the cost-benefit of advanced therapy lines for metastatic triple-negative breast cancer.
Camacho's scholarship metrics include an h-index of 23, with 57 total publications and 1,830 total citations. She has published on topics including polycyclic aromatic hydrocarbons and their methylated derivatives, as well as SARS-CoV-2 genome detection and variants. Key collaborators include Camila Silva, Michelle M. Vanlandingham, Frederick A. Beland, and Alec T. Salminen, all from the National Center for Toxicological Research, with whom she has co-authored three publications each.
Metrics
- h-index: 23
- Publications: 57
- Citations: 1,843
Selected Publications
-
Pharmacokinetics of cannabidiol and its metabolites in rhesus monkeys and New Zealand White rabbits (2025)
-
Wastewater dataset on the SARS-CoV-2 sublineages circulating in Central Arkansas, USA, post-COVID-19 pandemic (2025)
-
P19-17 Use of diverse human skin models in in vitro skin permeation testing of dermatological ingredients (2024)
-
The effect of black cohosh extract and risedronate coadministration on bone health in an ovariectomized rat model (2024)
-
Race, pigmentation, and the human skin barrier—considerations for dermal absorption studies (2023)
-
Polycyclic Aromatic Hydrocarbons, Methylated Polycyclic Aromatic Hydrocarbons, and Polycyclic Azaaromatic Compounds (2023)
-
Parallel evaluation of alternative skin barrier models and excised human skin for dermal absorption studies in vitro (2023)
-
Temporal dynamics of SARS-CoV-2 genome and detection of variants of concern in wastewater influent from two metropolitan areas in Arkansas (2022)
-
A robust biostatistical method leverages informative but uncertainly determined qPCR data for biomarker detection, early diagnosis, and treatment (2022)
Collaboration Network
Top Collaborators
- Temporal dynamics of SARS-CoV-2 genome and detection of variants of concern in wastewater influent from two metropolitan areas in Arkansas
- A robust biostatistical method leverages informative but uncertainly determined qPCR data for biomarker detection, early diagnosis, and treatment
- Wastewater dataset on the SARS-CoV-2 sublineages circulating in Central Arkansas, USA, post-COVID-19 pandemic
- Parallel evaluation of alternative skin barrier models and excised human skin for dermal absorption studies in vitro
- Race, pigmentation, and the human skin barrier—considerations for dermal absorption studies
- P19-17 Use of diverse human skin models in in vitro skin permeation testing of dermatological ingredients
- Parallel evaluation of alternative skin barrier models and excised human skin for dermal absorption studies in vitro
- Polycyclic Aromatic Hydrocarbons, Methylated Polycyclic Aromatic Hydrocarbons, and Polycyclic Azaaromatic Compounds
- Pharmacokinetics of cannabidiol and its metabolites in rhesus monkeys and New Zealand White rabbits
- Parallel evaluation of alternative skin barrier models and excised human skin for dermal absorption studies in vitro
- Race, pigmentation, and the human skin barrier—considerations for dermal absorption studies
- P19-17 Use of diverse human skin models in in vitro skin permeation testing of dermatological ingredients
- The effect of black cohosh extract and risedronate coadministration on bone health in an ovariectomized rat model
- Wastewater dataset on the SARS-CoV-2 sublineages circulating in Central Arkansas, USA, post-COVID-19 pandemic
- Pharmacokinetics of cannabidiol and its metabolites in rhesus monkeys and New Zealand White rabbits
- Temporal dynamics of SARS-CoV-2 genome and detection of variants of concern in wastewater influent from two metropolitan areas in Arkansas
- Wastewater dataset on the SARS-CoV-2 sublineages circulating in Central Arkansas, USA, post-COVID-19 pandemic
- Temporal dynamics of SARS-CoV-2 genome and detection of variants of concern in wastewater influent from two metropolitan areas in Arkansas
- Wastewater dataset on the SARS-CoV-2 sublineages circulating in Central Arkansas, USA, post-COVID-19 pandemic
- Temporal dynamics of SARS-CoV-2 genome and detection of variants of concern in wastewater influent from two metropolitan areas in Arkansas
- Wastewater dataset on the SARS-CoV-2 sublineages circulating in Central Arkansas, USA, post-COVID-19 pandemic
- Cannabis use among patients presenting to the emergency department for psychosis: Associations with restraint use, medication administration, psychiatric hospitalization, and repeat visits
- Feasibility and Acceptability of a Single-session Self-regulation Intervention to Increase Physical Activity in Individuals with Serious Mental Illness: Results from a Pilot Open Trial
- Parallel evaluation of alternative skin barrier models and excised human skin for dermal absorption studies in vitro
- P19-17 Use of diverse human skin models in in vitro skin permeation testing of dermatological ingredients
- Parallel evaluation of alternative skin barrier models and excised human skin for dermal absorption studies in vitro
- P19-17 Use of diverse human skin models in in vitro skin permeation testing of dermatological ingredients
- Validation of an ICD-Code-Based Case Definition for Psychotic Illness Across Three Health Systems
- Validation of an ICD-code-based case definition for psychotic illness across three health systems
- Validation of an ICD-Code-Based Case Definition for Psychotic Illness Across Three Health Systems
- Validation of an ICD-code-based case definition for psychotic illness across three health systems
- Validation of an ICD-Code-Based Case Definition for Psychotic Illness Across Three Health Systems
- Validation of an ICD-code-based case definition for psychotic illness across three health systems
- Validation of an ICD-Code-Based Case Definition for Psychotic Illness Across Three Health Systems
- Validation of an ICD-code-based case definition for psychotic illness across three health systems
Similar Researchers
Based on overlapping research topics